Home › Funds › WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST › NMRA

WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST position in NMRA

NEUMORA THERAPEUTICS INC. · Health Care

WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST reported holding 3,309,123 shares of NMRA (NEUMORA THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.02% of its reported portfolio and ranking #23 among its reported holdings. WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST has disclosed NMRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.31M sh
Reported value held$1.97M
Portfolio Weight0.02%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST's NMRA position evolved

WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST first disclosed a stake in NMRA in Q3 2023 at 3,309,124 shares (US$46.7M). The position peaked in Q4 2023 at 3,309,123 shares, worth US$56.4M. Across 13 filings, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST held the position steady without any share-count change. The most recent filing (Q3 2026) shows 3,309,123 shares valued at US$2.0M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.31M $46.69M New
Q4 2023 3.31M $56.42M Hold
Q1 2024 3.31M $45.50M Hold
Q2 2024 3.31M $32.53M Hold
Q3 2024 3.31M $43.71M Hold
Q4 2024 3.31M $35.08M Hold
Q1 2025 3.31M $3.31M Hold
Q2 2025 3.31M $2.43M Hold
Q3 2025 3.31M $6.02M Hold
Q4 2025 3.31M $5.92M Hold
Q1 2026 3.31M $6.45M Hold
Q2 2026 3.31M $5.63M Hold
Q3 2026 3.31M $1.97M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NMRA and 13F data

NMRA (NEUMORA THERAPEUTICS INC.) is a Health Care company. 17 other funds we track also report a position in NMRA — the largest reported positions include SOFTBANK GROUP CORP. (US$10.4M), MIC Capital Management UK LLP (US$7.6M), ICONIQ Capital, LLC (US$4.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NMRA

All NMRA fund holders →

FAQ

How long has WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST held NMRA?

WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST has disclosed NMRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST's current position in NMRA?

As of Q3 2026, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST holds 3.31M shares of NMRA (NEUMORA THERAPEUTICS INC.), valued at $1.97M, representing 0.02% of its reported portfolio and ranking #23.

Has WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST been buying or selling NMRA?

In the latest 13F filing (Q3 2026), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST held unchanged its position in NMRA. The position peaked in Q4 2023 at 3.31M shares.

Which other funds hold NMRA?

Other major institutional holders of NMRA include SOFTBANK GROUP CORP., MIC Capital Management UK LLP, ICONIQ Capital, LLC, among 17 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.